CryoLife Announces Release Date and Teleconference Call Details for the Fourth Quarter and Year End 2007 Financial Results
January 31 2008 - 8:30AM
PR Newswire (US)
ATLANTA, Jan. 31 /PRNewswire-FirstCall/ -- CryoLife, Inc.
(NYSE:CRY), a biomaterials, medical device and tissue processing
company, announced today that fourth quarter and year end 2007
financial results will be released on Thursday, February 21, 2008.
The Company will hold a teleconference call and live webcast at
10:00 a.m. Eastern Time, February 21, 2008, to discuss the results
followed by a question and answer session hosted by Steven G.
Anderson, president and chief executive officer of CryoLife, Inc.
To listen to the live teleconference please dial 201-689-8261 a few
minutes prior to 10:00 a.m. A replay of the teleconference will be
available February 21 through February 28, 2008 and can be accessed
by calling (toll free) 877-660-6853 or 201-612-7415. The account
number for the replay is 244 and the conference number is 271923.
The live webcast and replay can be accessed by going to the
Investor Relations section of the CryoLife Web site at
http://www.cryolife.com/ and selecting the heading Webcasts &
Presentations. About CryoLife, Inc. Founded in 1984, CryoLife, Inc.
is a leader in the processing and distribution of implantable
living human tissues for use in cardiac and vascular surgeries
throughout the United States and Canada. The Company's BioGlue(R)
Surgical Adhesive is FDA approved as an adjunct to sutures and
staples for use in adult patients in open surgical repair of large
vessels. BioGlue is also CE marked in the European Community and
approved in Canada and Australia for use in soft tissue repair. The
Company also distributes the CryoLife-O'Brien(R) stentless porcine
heart valve, which is CE marked for distribution within the
European Community. For additional information about the company,
visit CryoLife's Web site: http://www.cryolife.com/ Media Contacts:
D. Ashley Lee Executive Vice President, Chief Operating Officer and
Chief Financial Officer Phone: 770-419-3355 Katie Brazel Fleishman
Hillard Phone: 404-739-0150 DATASOURCE: CryoLife, Inc. CONTACT: D.
Ashley Lee, Executive Vice President, Chief Operating Officer and
Chief Financial Officer of CryoLife, Inc., +1-770-419-3355; or
Katie Brazel, Fleishman Hillard, +1-404-739-0150 Web site:
http://www.cryolife.com/
Copyright
CryoLife (NYSE:CRY)
Historical Stock Chart
From May 2024 to Jun 2024
CryoLife (NYSE:CRY)
Historical Stock Chart
From Jun 2023 to Jun 2024